A Study of TRK-170 for the Treatment of Crohn's Disease

Extension Study of MT-1303 in Subjects With Crohn's Disease

NCT02389790 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

NCT00584740 ·Status: TERMINATED ·Phase: PHASE2

Immune Ablation and Stem Cell Support for Crohn's Disease

NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2

CNI-1493 for Treatment of Moderate to Severe Crohn's Disease

NCT00038766 ·Status: TERMINATED ·Phase: PHASE2

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

NCT02450513 ·Status: COMPLETED

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

NCT00792740 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

NCT00101946 ·Status: COMPLETED ·Phase: PHASE2

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

NCT01751152 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02015793 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy

NCT02793778 ·Status: TERMINATED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

NCT04173273 ·Status: TERMINATED ·Phase: PHASE3

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

NCT06450197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

NCT03599622 ·Status: TERMINATED ·Phase: PHASE2

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

NCT06233461 ·Status: RECRUITING ·Phase: PHASE2

Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

NCT01540292 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

NCT02148185 ·Status: COMPLETED ·Phase: PHASE1

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Moderate to Severe Refractory Crohn's Disease

NCT06721962 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

NCT01714726 ·Status: COMPLETED ·Phase: PHASE2

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

NCT00152490 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission

NCT01820247 ·Status: UNKNOWN ·Phase: NA

A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease

NCT01635621 ·Status: WITHDRAWN ·Phase: PHASE2